NASDAQ:EDIT | Free Cash Flow | Editas Medicine, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2014-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$23.06M$92,000.00-$23.15M
2025-12-31-$36.39M$60,000.00-$36.45M
2025-03-31-$47.8M$114,000.00-$47.91M
2024-12-31-$50.76M$540,000.00-$51.3M
2024-03-31-$49.87M$1.87M-$51.74M
2023-12-31-$22.24M$1.31M-$23.55M
2023-03-31-$35.77M$1.84M-$37.61M
2022-12-31-$42.27M$624,000.00-$42.9M
2022-03-31-$49.23M$2.25M-$51.48M
2021-12-31-$34.58M$2.85M-$37.43M
2021-03-31-$49.48M$84,000.00-$49.56M
2020-12-31-$40.1M$1.38M-$41.48M
2020-03-31-$54.09M$2.15M-$56.24M
2019-12-31$41.02M$1.69M$39.33M
2019-03-31-$29M$718,000.00-$29.72M
2018-12-31$1.33M$1.42M-$88,000.00
2018-03-31-$22.46M$1.01M-$23.47M
2017-12-31-$25.07M$289,000.00-$25.36M
2017-03-31$69.79M$656,000.00$69.14M
2016-12-31-$13.68M$676,000.00-$14.35M
2016-03-31-$9.63M$943,000.00-$10.57M
2015-12-31-$8.01M$401,000.00-$8.41M
2015-03-31-$5.94M$305,000.00-$6.25M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$165.24M$607,000.00-$165.85M
2024-12-31-$210.28M$8.83M-$219.11M
2023-12-31-$132.18M$4.72M-$136.9M
2022-12-31-$177.35M$4.12M-$181.47M
2021-12-31-$163.8M$7.98M-$171.78M
2020-12-31-$179.84M$7.16M-$187.01M
2019-12-31-$40.67M$6.17M-$46.84M
2018-12-31-$45.71M$4.75M-$50.46M
2017-12-31-$9.42M$2.06M-$11.48M
2016-12-31-$50.25M$3.49M-$53.74M
2015-12-31-$5.44M$1.43M-$6.87M
2014-12-31-$8.66M$1.22M-$9.87M